(Reuters] – The initial public offering of Bausch + Lomb was priced below its range by the eyecare company Bausch + Lomb. This has scuttled any hopes of a revival on the market for news, as inflation is a major concern.

Only a few businesses have listed their shares recently on Wall Street. This has received very little attention.

Below is a listing of stocks that performed well in the largest IPOs of 2022.

U.S. Listings Month of Capital Stock

In 2022, performance was improved by listing

since debut

TPG Inc January $1 Bln -21.2%

Excelerate April 442 Mln -7.2%

Energy Inc

Credo January 200 mln 9.8%

Technology

Group Holding

Ltd

HilleVax Inc April $230 mln -13.2%

CinCor Pharma January $194 Mln +18.7%

Inc

Amylyx January $190 Mln -56%

Pharmaceuticals

Inc

Source: Refinitiv